Instrumento Inactivo

Otros idiomas Mind Medicine (MindMed) Inc. Other OTC

Acciones

MMEDF

CA60255C1095

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

MindMed APA 2024: Screening Adults in the US General Population to Detect Cases of Undiagnosed Generalized Anxiety Disorder	14:03
MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York	14:01
MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update	02/05
MindMed to Present at Upcoming May Medical Conferences	25/04
MindMed to Present at Upcoming April Medical Conferences	02/04
MindMed Announces Voluntary Delisting from Cboe Canada	01/04
Mind Medicine Inc. announced that it has received $75 million in funding from Deep Track Capital, LP, Commodore Capital	18/03
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference	11/03
Numinus Wellness Congratulates Mindmed on Positive Results from Phase 2B Clinical Trials of Mm120 for Generalized Anxiety Disorder	08/03
Sector Update: Health Care Stocks Gain Late Afternoon	07/03
Sector Update: Health Care Stocks Stronger in Afternoon Trading	07/03
Mind Medicine Gets FDA Breakthrough for Anxiety Treatment, Sees $175 Million in Proceeds From Stock Offerings; Shares Jump	07/03
Mind Medicine MindMed : Investor Presentation - MM120 for Generalized Anxiety Disorder Conference Call and Webcast	07/03
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement	07/03
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder	07/03
Mind Medicine Inc. Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data from Phase 2B Study of MM120 for Generalized Anxiety Disorder	07/03
Mind Medicine Inc. announced that it expects to receive $75 million in funding from Deep Track Capital, LP, Commodore Capital	07/03
Thinking about buying stock in Minim, GameSquare, Laser Photonics, Geron, or Mind Medicine?	01/03
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120	01/03
Mind Medicine Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Mind Medicine (MindMed) Inc. Other OTC

Acciones

MMEDF

CA60255C1095

Otros idiomas

Filtros